3-Hydroxyglutaric acid (3-OH-GA) is an organic acid with the chemical formula C5H8O5, existing in two enantiomers: D-2-hydroxyglutarate (D-2-HG) and L-2-hydroxyglutarate (L-2-HG).
It plays a critical role in amino acid catabolism, particularly in the breakdown of lysine, tryptophan, and hydroxylysine.
This compound is most notably associated with glutaric aciduria type I (GA I), a rare inherited metabolic disorder caused by a deficiency in the enzyme glutaryl-CoA dehydrogenase (GCDH).
In GA I, the inability to properly break down glutaryl-CoA leads to its accumulation, which is subsequently converted to 3-OH-GA by mitochondrial enzymes.
This process involves the conversion of glutaryl-CoA to glutaconyl-CoA by medium-chain acyl-CoA dehydrogenase (MCAD), followed by the action of 3-methylglutaconyl-CoA hydratase (3-MGH). Elevated levels of 3-OH-GA in urine serve as a reliable diagnostic marker for GA I and other metabolic disorders involving mitochondrial dysfunction and fatty acid oxidation.
The measurement of 3-OH-GA levels is essential in assessing GCDH activity and overall metabolic health in affected patients.
3-Hydroxyglutaric acid is an organic acid with the chemical formula C5H8O5. 3-hydroxyglutaric acid exists in 2 enantiomers, D-2-hydroxyglutarate (D-2-HG) and L-2-hydroxyglutarate (L-2-HG).
It is a metabolite involved in amino acid catabolism and has been extensively studied in the context of a rare inherited metabolic disorder called glutaric aciduria type I (GA1). [1., 5.]
3-hydroxyglutaric acid is mainly described as an intermediate in amino acid catabolism, particularly in the breakdown of lysine, tryptophan, and hydroxylysine. [6.]
Elevated levels of 3-hydroxyglutaric acid are a clinical sign of glutaric aciduria type I, which is caused by a deficiency in the enzyme glutaryl-CoA dehydrogenase (GCDH). Glutaric aciduria type I, a condition characterized by macrocephaly (abnormally large head), spasticity, dystonia, and potential seizures and coma. [5.]
When present in sufficiently high levels, 3-hydroxyglutaric acid can act as an acidogen (a compound that induces acidosis) and a metabotoxin (an endogenously produced metabolite that causes adverse health effects at chronically high levels). [5.]
3-Hydroxyglutaric acid (3-OH-GA) is a critical diagnostic marker for glutaric aciduria type I (GA I), a metabolic disorder characterized by the deficiency of glutaryl-CoA dehydrogenase (GCDH).
In GA I, the impaired breakdown of glutaryl-CoA to crotonyl-CoA leads to the accumulation of glutaryl-CoA, which is then converted to 3-OH-GA through a series of reactions involving mitochondrial enzymes.
Specifically, 3-methylglutaconyl-CoA hydratase (3-MGH) catalyzes the conversion of glutaconyl-CoA to 3-hydroxyglutaryl-CoA, which is subsequently hydrolyzed to 3-OH-GA.
This pathway operates with the involvement of medium-chain acyl-CoA dehydrogenase (MCAD), which effectively converts glutaryl-CoA to glutaconyl-CoA despite its low turnover rate.
In patients with GA I, 3-OH-GA is consistently produced and excreted in urine, making it a reliable indicator of the disorder regardless of the variability in glutaric acid excretion.
The detection of 3-OH-GA in urine aids in diagnosing not only GA I but also other metabolic conditions involving mitochondrial dysfunction and fatty acid oxidation disorders.
The measurement of 3-OH-GA levels provides a sensitive assessment of GCDH activity and metabolic health, making it an essential tool in the clinical evaluation of these patients.
Organic acids are organic compounds with acidic properties. They include a variety of functional groups like carboxyl, phenol, enol, and thiol, with carboxylic acids having the strongest acidity.
Organic acids are considered weak acids, with those containing phenol, enol, alcohol, or thiol groups being even weaker.
Their structures vary in terms of carbon chain types—aromatic, aliphatic, alicyclic, heterocyclic—saturation, substitutions, and the number of functional groups.
These acids play critical roles in metabolic and catabolic pathways, notably in the tricarboxylic acid cycle inside mitochondria, which is central to energy production in eukaryotes. They are also pivotal in determining the sensory properties of fruits and vegetables.
Organic acid disorders are inherited metabolic conditions that affect the enzymes or transport proteins essential for the breakdown of amino acids, lipids, or carbohydrates. They are marked by the excessive excretion of non-amino organic acids in urine, primarily due to defects in specific enzymes involved in amino acid breakdown that cause buildup of organic acids in tissues.
Conditions can manifest as inborn metabolic disorders of organic acids and amino acids, urea cycle anomalies, and mitochondrial respiratory chain deficiencies.
These disorders are typically passed down through autosomal recessive inheritance. They often present in newborns with symptoms like vomiting and lethargy, progressing to more severe neurological symptoms.
Early diagnosis and intervention are critical and can improve outcomes. Diagnostic methods include urine organic acid analysis via gas chromatography-mass spectrometry (GC/MS).
Current treatments focus on managing symptoms and preventing complications, although definitive therapies are still under research. Treatment focuses may include dietary management, detoxifying harmful metabolites, and in severe cases, organ transplantation.
Continuous monitoring and management are essential for managing symptoms and preventing complications.
Increasingly, research highlights new relationships between the microbiome and human health. Many organisms that comprise the microbiome produce organic acids that can then be tested for additional diagnostic capability.
Certain organic acids in urine like hippuric acid, benzoic acid, and indoleacetic acid are metabolites produced by gut bacteria from the breakdown of amino acids, dietary polyphenols, and other substances.
These acids provide insights into gut health and metabolic functions. For example, elevated levels of certain acids may indicate gut dysbiosis or specific metabolic imbalances, such as phenylketonuria.
Some organic acids known to be produced by the microbiome include:
Benzoic Acid (BA):
Produced from phenylalanine and polyphenol metabolism by intestinal bacteria. High levels in urine can indicate glycine deficiency or liver dysfunction.
Hippuric Acid (HA):
Formed in the liver by conjugation of benzoic acid with glycine. Elevated levels may indicate exposure to environmental toxins like toluene.
Phenylacetic Acid (PAA) and Phenylpropionic Acid (PPA):
These acids result from phenylalanine metabolism by gut bacteria. High urinary levels can suggest dysbiosis or disorders like phenylketonuria. PAA is also associated with depression markers.
4-Hydroxybenzoic Acid (4-HBA) and 4-Hydroxyphenylacetic Acid (4-HPAA):
Derivatives of tyrosine metabolism. 4-HBA is linked to catechin (green tea) metabolism, and 4-HPAA is useful in diagnosing small bowel diseases related to bacterial overgrowth.
3-Hydroxyphenylpropionic Acid (3-HPPA):
A metabolite from dietary polyphenols like proanthocyanidins, indicative of robust bacterial metabolism in the intestines.
3,4-Dihydroxyphenyl Propionic Acid (3,4-DHPPA):
Produced from dietary quinolones by clostridial species, with high levels suggesting an overgrowth.
3-Indoleacetic Acid (IAA): A breakdown product of tryptophan by gut bacteria such as Bifidobacterium and Bacteroides. Elevated levels are seen in conditions like phenylketonuria or dietary changes.
These organic acids are important markers in clinical diagnostics, helping to monitor metabolic disturbances, gut microbiota balance, and exposure to environmental toxins.
Their presence and concentration are influenced by diet, gut microbiota composition, and overall metabolic health, making them valuable indicators in clinical settings for assessing both metabolic and gastrointestinal conditions.
Organic Acid Testing in Functional Medicine
In functional medicine, organic acid testing is utilized to evaluate a patient's metabolic function through a simple urine test. This testing can identify metabolic imbalances that may affect a patient’s mood, energy, and overall health.
Testing provides insights into nutrient deficiencies, dietary habits, toxic exposures, and gut microbiome activity.
The results assist practitioners in customizing treatment plans to address specific metabolic dysfunctions and improve health outcomes.
Additionally, it helps in assessing the impact of microbial metabolism and the efficiency of the Krebs Cycle, aiding in personalized healthcare.
Laboratory testing for organic acids including 3-Hydroxyglutaric Acid is typically done in urine, although it can also be tested in blood. Testing may be ordered to diagnose an inborn metabolic disorder, or to assess metabolic function and gastrointestinal health in a functional medicine setting.
Urine samples may be collected in a clinical setting; they can also be collected at home. Some labs recommend or require a first morning void sample, to provide a concentrated sample.
Generally, falling within reference ranges for organic acids is recommended, although for many of these organic acids, a level towards the lower end of the reference range is considered optimal.
It is essential to consult with the laboratory company used for their recommended reference range for 3-Hydroxyglutaric Acid.
One company reports the following reference range for 3-Hydroxyglutaric Acid: </= 4.6 mmol/mol/creatinine. [10.]
Elevated levels of 3-hydroxyglutaric acid are clinically relevant as they are associated with the rare inherited metabolic disorder called glutaric aciduria type I (GA1), also known as glutaric acidemia type I or glutaryl-CoA dehydrogenase deficiency.
Low levels of 3-Hydroxyglutaric Acid are not considered clinically relevant.
3-Hydroxyglutaric Acid is typically tested along with other organic acids to gain deeper insights into metabolic pathways and physiological processes.
Organic acids that may be tested as part of a panel include:
2-Hydroxybutyric Acid: this acid is a marker for insulin resistance and increased oxidative stress.
2-Hydroxyphenylacetic Acid: derived from phenylalanine metabolism, this acid is used as a biomarker in various metabolic assessments.
3-Hydroxybutyric Acid: a ketone body produced during fat metabolism, indicative of carbohydrate deprivation or ketogenic conditions.
3-Hydroxyisovaleric Acid: an organic acid that accumulates in leucine catabolism disorders, often elevated in maple syrup urine disease.
3-Indoleacetic Acid: a metabolite of tryptophan, it is significant in the study of serotonin pathways and plant growth regulation.
4-Hydroxybenzoic Acid: a derivative of tyrosine metabolism, it is linked to catechin (green tea) metabolism and may be produced by some intestinal bacteria.
4-Hydroxyphenylacetic Acid: a breakdown product of tyrosine, used in diagnosing disorders involving the degradation of aromatic amino acids.
5-Hydroxyindoleacetic Acid: the main metabolite of serotonin, used as a marker in the diagnosis of carcinoid syndrome.
Adipic Acid: a dicarboxylic acid that can also be formed metabolically in humans through the oxidation of certain fatty acids.
a-Keto-b-Methylvaleric Acid: an intermediate in isoleucine metabolism, which can accumulate in certain metabolic disorders.
a-Ketoisocaproic Acid: an intermediate in the metabolism of leucine, elevated in maple syrup urine disease.
a-Ketoisovaleric Acid: a breakdown product of valine metabolism, also linked to maple syrup urine disease.
a-Ketoglutaric Acid: a key intermediate in the citric acid cycle, essential for energy production and nitrogen transport.
Benzoic Acid: produced from phenylalanine and polyphenol metabolism by intestinal bacteria. High levels in urine can indicate glycine deficiency or liver dysfunction.
Cis-Aconitic Acid: an intermediate in the tricarboxylic acid cycle, formed by the dehydration of citric acid.
Citric Acid: a central compound in the citric acid cycle, crucial for energy production in cells.
Ethylmalonic Acid: this acid accumulates in ethylmalonic encephalopathy and is involved in fatty acid metabolism.
Fumaric Acid: an intermediate in the tricarboxylic acid (TCA) cycle, participating in energy production through its conversion to malate and subsequent participation in the generation of ATP.
Homovanillic Acid: a major metabolite of dopamine, used as a marker to monitor dopamine levels.
Hippuric Acid: formed from the conjugation of benzoic acid and glycine; elevated levels can indicate exposure to certain environmental toxins.
Hydroxymethylglutarate: an intermediate in leucine metabolism, also associated with disorders of ketogenesis and ketolysis.
Isocitric Acid: an isomer of citric acid and an important part of the citric acid cycle, pivotal in cellular energy production.
Kynurenic Acid: a product of tryptophan metabolism, known for its role as a neuroprotective agent.
Lactic Acid: produced from pyruvate via anaerobic metabolism, an indicator of hypoxia and strenuous exercise.
Malic Acid: a dicarboxylic acid found in fruits, and involved in the citric acid cycle.
Methylmalonic Acid: an indicator of Vitamin B12 deficiency, it accumulates when the vitamin is deficient.
Methylsuccinic Acid: a dicarboxylic acid often involved in alternative pathways of fatty acid metabolism.
Orotic Acid: involved in the metabolism of pyrimidines, abnormalities in its levels can indicate metabolic disorders.
Pyroglutamic Acid: an uncommon amino acid derivative that can accumulate in glutathione synthesis disorders.
Pyruvic Acid: a key intersection in several metabolic pathways; its levels are crucial for assessing cellular respiration and metabolic function.
Quinolinic Acid: a neuroactive metabolite of the kynurenine pathway, elevated levels are associated with neurodegenerative diseases.
Suberic Acid: a dicarboxylic acid that is a biomarker in adipic aciduria, often studied in relation to fatty acid oxidation disorders.
Succinic Acid: a four-carbon dicarboxylic acid that plays a central role in the Krebs cycle, crucial for energy production.
Tricarballylic Acid: an organic acid that can inhibit aconitase in the citric acid cycle and is sometimes associated with glyphosate exposure.
Vanillylmandelic Acid: a metabolite of epinephrine and norepinephrine, used as a marker for neuroblastoma and other catecholamine-secreting tumors.
Click here to compare testing options and order organic acid testing.
[1.] 3-Hydroxyglutaric Acid (CAS 638-18-6). www.caymanchem.com. Accessed May 30, 2024. https://www.caymanchem.com/product/16334/3-hydroxyglutaric-acid
[2.] Beley GJ, Anne M, Dadia DM. Nutrigenomics in the management and prevention of metabolic disorders. Elsevier eBooks. Published online January 1, 2023:209-274. doi:https://doi.org/10.1016/b978-0-12-824412-8.00006-0
[3.] Chahardoli A, Jalilian F, Memariani Z, Farzaei MH, Shokoohinia Y. Analysis of organic acids. Recent Advances in Natural Products Analysis. Published online 2020:767-823. doi:https://doi.org/10.1016/b978-0-12-816455-6.00026-3
[4.] French D. Advances in Clinical Mass Spectrometry. Advances in Clinical Chemistry. 2017;79:153-198. doi:https://doi.org/10.1016/bs.acc.2016.09.003
[5.] Human Metabolome Database: Showing metabocard for 3-Hydroxyglutaric acid (HMDB0000428). Hmdb.ca. Published 2023. Accessed May 30, 2024. https://hmdb.ca/metabolites/HMDB0000428
[6.] Leandro J, Houten SM. The lysine degradation pathway: Subcellular compartmentalization and enzyme deficiencies. Molecular Genetics and Metabolism. 2020;131(1-2):14-22. doi:https://doi.org/10.1016/j.ymgme.2020.07.010
[7.] Lee YT, Huang SQ, Lin CH, Pao LH, Chiu CH. Quantification of Gut Microbiota Dysbiosis-Related Organic Acids in Human Urine Using LC-MS/MS. Molecules. 2022 Aug 23;27(17):5363. doi: 10.3390/molecules27175363. PMID: 36080134; PMCID: PMC9457824.
[8.] Peters V, Morath M, Mack M, et al. Formation of 3-hydroxyglutaric acid in glutaric aciduria type I: in vitro participation of medium chain acyl-CoA dehydrogenase. JIMD Reports. 2019;47(1):30-34. doi:https://doi.org/10.1002/jmd2.12026
[9.] PubChem. 3-Hydroxyglutaric acid. pubchem.ncbi.nlm.nih.gov. Accessed May 30, 2024. https://pubchem.ncbi.nlm.nih.gov/compound/3-Hydroxyglutaric-acid
[10.] Rupa Health. OAT Sample Report.pdf. Google Docs. https://drive.google.com/file/d/1lA81IDzMs3Q0myMwQR90ypXGCnFzgYGu/view
[11.] Ryan, D.G., Murphy, M.P., Frezza, C. et al. Coupling Krebs cycle metabolites to signalling in immunity and cancer. Nat Metab 1, 16–33 (2019). https://doi.org/10.1038/s42255-018-0014-7
[12.] Seashore M. The Organic Acidemias: An Overview.; 2001. Accessed May 2, 2024. https://corpora.tika.apache.org/base/docs/govdocs1/141/141031.pdf